Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Xeris Biopharma Holdings (XERS) Shares Outstanding: 2020-2025

Historic Shares Outstanding for Xeris Biopharma Holdings (XERS) over the last 5 years, with Sep 2025 value amounting to $165.5 million.

  • Xeris Biopharma Holdings' Shares Outstanding rose 11.09% to $165.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.5 million, marking a year-over-year increase of 11.09%. This contributed to the annual value of $149.4 million for FY2024, which is 8.18% up from last year.
  • Xeris Biopharma Holdings' Shares Outstanding amounted to $165.5 million in Q3 2025, which was up 2.67% from $161.2 million recorded in Q2 2025.
  • Xeris Biopharma Holdings' Shares Outstanding's 5-year high stood at $165.5 million during Q3 2025, with a 5-year trough of $66.3 million in Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding was $148.9 million (2024), whereas its average is $148.2 million.
  • Data for Xeris Biopharma Holdings' Shares Outstanding shows a peak YoY surged of 109.48% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Xeris Biopharma Holdings' Shares Outstanding stood at $124.9 million in 2021, then increased by 9.13% to $136.3 million in 2022, then increased by 1.36% to $138.1 million in 2023, then climbed by 8.18% to $149.4 million in 2024, then grew by 11.09% to $165.5 million in 2025.
  • Its last three reported values are $165.5 million in Q3 2025, $161.2 million for Q2 2025, and $156.0 million during Q1 2025.